Momenta Pharmaceuticals Inc. was a big mover last session, as its shares rose a little over 11% on the day. The move came on the back of positive patent trial. This led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.13 to $12.49 in the past one-month time frame..

Over the last 30 days, the company witnessed two positive estimate revisions and one negative revision while the Zacks Consensus Estimate moved lower over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Momenta Pharmaceuticals currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

MOMENTA PHARMA Price

 

MOMENTA PHARMA Price | MOMENTA PHARMA Quote

A better-ranked stock in the med-biomed/gene space is Geron Corporation (GERN Quick QuoteGERN - Free Report) , which sports a Zacks Rank #1 (Strong Buy).

Is MNTA going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>